| Filed On | Filing |
|---|---|
| 09 Oct 2026 | Proxy statement: annual meeting on November 12, 2026 |
| 14 Sep 2026 |
8-K: Shareholder Director Nominations; Other Events
To the extent applicable, the information set forth below under Item 8.01 of this Current Report on Form 8-K “Notice of Annual Meeting” is incorporated by reference into this Item 5.08. |
| 02 Sep 2026 |
Form 4: Adams Julian, Director
Granted 21,750 Stock Option (Right to Buy) |
| 02 Sep 2026 |
Form 4: Ashe Carol Gail, Director
Granted 21,750 Stock Option (Right to Buy) |
| 02 Sep 2026 |
Form 4: Chudnovsky Yekaterina, Director
Granted 21,750 Stock Option (Right to Buy) |
| 02 Sep 2026 |
Form 4: Nissenson Allen, Director
Granted 21,750 Stock Option (Right to Buy) |
| 02 Sep 2026 |
Form 4: Ruffolo Robert R, Director
Granted 21,750 Stock Option (Right to Buy) |
| 02 Sep 2026 |
Form 4: Wilson Karen J, Director
Granted 21,750 Stock Option (Right to Buy) |
| 02 Sep 2026 |
Form 4: Venkatesan Jay, Director
Granted 21,750 Stock Option (Right to Buy) |
| 13 Aug 2026 | 10-Q |
| 13 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 17 Jul 2026 |
Form 4: Haqq Christopher, See Remarks
Granted 64,643 Stock Option (Right to Buy) |
| 17 Jul 2026 |
Form 4: DeMuth Peter, Chief Scientific Officer
Granted 52,832 Stock Option (Right to Buy) |
| 17 Jul 2026 |
Form 4: Shah Preetam, See Remarks
Granted 60,833 Stock Option (Right to Buy) |
| 17 Jul 2026 |
Form 4: Connelly Robert, Director
Granted 186,944 Stock Option (Right to Buy) |
| 16 Jul 2026 | SCHEDULE 13G |
| 08 Jul 2026 | SCHEDULE 13G/A |
| 02 Jul 2026 | 424B5 |
| 02 Jul 2026 | 8-K: Entry into a Material Definitive Agreement; Other Events |
| 24 Jun 2026 | 8-K: Regulation FD Disclosure |
Loading...
